Arterolane–piperaquine–mefloquine versus arterolane–piperaquine and artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial

Hamaluba M., van der Pluijm RW., Weya J., Njuguna P., Ngama M., Kalume P., Mwambingu G., Ngetsa C., Wambua J., Boga M., Mturi N., Lal AA., Khuroo A., Taylor WRJ., Gonçalves S., Miotto O., Dhorda M., Mutinda B., Mukaka M., Waithira N., Hoglund RM., Imwong M., Tarning J., Day NPJ., White NJ., Bejon P., Dondorp AM.

DOI

10.1016/s1473-3099(20)30929-4

Type

Journal

The Lancet Infectious Diseases

Publisher

Elsevier BV

Publication Date

10/2021

Volume

21

Pages

1395 - 1406

Permalink Original publication